A Real e Benemérita Associação Portuguesa de Beneficência
Welcome,         Profile    Billing    Logout  
 4 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Maluf, Fernando
COAction, NCT06627530: COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer

Not yet recruiting
4
144
NA
Darolutamide Oral Tablet, leuprorelin
Brazilian Clinical Research Institute, Bayer
Prostate Cancer
03/26
09/26
ODYSSEY, NCT04373564: Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

Recruiting
4
2076
Europe, Canada, US, RoW
Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain, Gadolinium Measurements, Gadoxetate disodium, Eovist, Primovist, BAY86-4873, Gadobenate dimeglumine, MultiHance, Gadodiamide, Omniscan, Gadoterate meglumine, Dotarem, Magnescope, Gadobutrol, BAY86-4875, Gadavist, Gadovist, Gadoteridol, ProHance
Guerbet, Bayer AG (Sponsor), Bracco (Sponsor), GEHC (Sponsor)
Motor Function, Cognitive Function, Contrast Media
12/28
12/28
innovaTV 301, NCT04697628 / 2019-001655-39: Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer

Active, not recruiting
3
502
Europe, Canada, Japan, US, RoW
tisotumab vedotin, TIVDAK, topotecan, vinorelbine, gemcitabine, irinotecan, pemetrexed
Seagen Inc., Genmab
Cervical Cancer
07/23
08/25
HERCULES, NCT04224740: Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer

Completed
2
37
RoW
Pembrolizumab, Standard of care therapy, Cisplatin(or Carboplatin), 5-fluouracil
Latin American Cooperative Oncology Group, Merck Sharp & Dohme LLC
Penile Carcinoma
11/23
11/23
ExBAT, NCT04558866: Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer ( Trial)

Active, not recruiting
2
51
RoW
Testosterone Cypionate, Deposteron, Darolutamide, Nubeqa
Latin American Cooperative Oncology Group, Bayer
Prostate Cancer
03/24
06/25
REPRESENTATION, NCT06527690: Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer

Not yet recruiting
2
70
NA
Niraparib/Abirate rone acetate fixed-dose combination, Prednisone
Latin American Cooperative Oncology Group, Janssen, LP
Prostate Cancer, Castrate Resistant Prostate Cancer, Homologous Recombination Deficiency
09/27
02/29
NCT05492123: Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Recruiting
2
112
RoW
Nivolumab 40 mg in 4 ml Injection, Opdivo, Ipilimumab 200 MG in 40 ML Injection, Yervoy, Chemoradiation, Cisplatin-based chemoradiation
Hospital Israelita Albert Einstein, Bristol-Myers Squibb, Brava
Uterine Cervical Neoplasms
12/26
03/28
GARNET, NCT02715284: Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid Tumors

Checkmark MFDS approved in Korea in adult patients with recurrent or advanced dMMR/MSI-H 2L endometrial cancer
Dec 2022 - Dec 2022: MFDS approved in Korea in adult patients with recurrent or advanced dMMR/MSI-H 2L endometrial cancer
Checkmark Result from GARNET trial for dMMR endometrial cancer and other solid tumors at ESMO 2022
Sep 2022 - Sep 2022: Result from GARNET trial for dMMR endometrial cancer and other solid tumors at ESMO 2022
Checkmark Approved for recurrent or advanced endometrial cancer
More
Recruiting
1
740
Europe, Canada, US, RoW
Dostarlimab
Tesaro, Inc.
Neoplasms
05/26
10/27
NCT05945108: Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

Completed
N/A
400
RoW
AstraZeneca, Hospital Israelita Albert Einstein
Urothelial Carcinoma, Non Muscle Invasive Bladder Cancer, Muscle-invasive Bladder Cancer
04/24
04/24
LACOG 1818, NCT04962919: Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

Active, not recruiting
N/A
584
RoW
Latin American Cooperative Oncology Group
Prostatic Neoplasms, Castration-Resistant
08/24
08/24
PROCeed-BR, NCT06457854: Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+Abiraterone

Not yet recruiting
N/A
80
RoW
AstraZeneca
Prostatic Neoplasms
12/25
12/25
IRONMAN, NCT03151629: International Registry for Men With Advanced Prostate Cancer

Recruiting
N/A
5000
Europe, Canada, US, RoW
Standard of Care
Prostate Cancer Clinical Trials Consortium
Prostate Cancer
01/29
01/29

Download Options